Text Size

Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

This study has been completed.
Sponsor:
Collaborator:
Scientific research fund Bruges
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221559
First received: September 12, 2005
Last updated: May 7, 2006
Last verified: May 2006
History of Changes
  Purpose

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group


Condition Intervention
Cystic Fibrosis
 Procedure: Blood sampling for determination of serum Zn

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

Resource links provided by NLM:

MedlinePlus related topics: Cystic Fibrosis
U.S. FDA Resources

Further study details as provided by University Hospital, Ghent:

Estimated Enrollment: 0
Study Start Date: September 2004
Detailed Description:

Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cystic fibrosis

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00221559

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Scientific research fund Bruges
Investigators
Principal Investigator: Stephanie Van Biervliet, MD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

Publications:

ClinicalTrials.gov Identifier: NCT00221559     History of Changes
Other Study ID Numbers: UZGhent 001
Study First Received: September 12, 2005
Last Updated: May 7, 2006
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
 Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 16, 2013